Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded AstraZeneca Pharma India Limited (ASTRAZEN.BO) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against J. B. Chemicals & Pharmaceuticals Limited, J. B. Chemicals & Pharmaceuticals Limited, Wockhardt Limited, Wockhardt Limited, Neuland Laboratories Limited, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| JBCHEPHARM.NS | J. B. Chemicals & Pharmaceuticals Limited | $369.6B |
| JBCHEPHARM.BO | J. B. Chemicals & Pharmaceuticals Limited | $366.7B |
| WOCKPHARMA.BO | Wockhardt Limited | $315.8B |
| WOCKPHARMA.NS | Wockhardt Limited | $315.6B |
| NEULANDLAB.BO | Neuland Laboratories Limited | $237.2B |
| NEULANDLAB.NS | Neuland Laboratories Limited | $236.3B |
| PPLPHARMA.BO | Piramal Pharma Limited | $223.2B |
| PEL.NS | PEL.NS | — |
| ERIS.NS | ERIS.NS | — |
| ERIS.BO | ERIS.BO | — |